2013.07.15 Weekly Broadcast Email
following updates were made to the CCCWF CCOP Research Base website for the
week of July 15, 2013.
(Feasibility of Delivering a Quitline Based Smoking
Cessation Intervention in Cancer Patients Receiving Outpatient Treatment: A
be aware if a patient is enrolled in protocol 99211 the following requirements
for SAE’s are defined in Section 10.2 of the protocol. Grades 3, 4 and 5
SAE’s meeting the criteria for a Medwatch need to be reported in both the
Quitline Intervention Group and the Usual Care Group. If you have
patients in which a Medwatch needs to be submitted, please do so as soon as
Annual Meeting Registration:
CCCWF CCOP Research Base 13th Annual Meeting will be held October
24-26 in Asheville, NC. Please visit our annual meeting website for the meeting
agenda, accommodation information, and registration. We look forward to
seeing you in October!
(A Randomized Phase II Dose Finding Study of ArginMax with or without
Phosphodiesterase-5 Inhibitors for Its Effect on Erectile Function and Quality
of Life in Survivors of Prostate Cancer Previously Treated with Radiotherapy)
2013 Continuing Review WF Approval Letter has been posted to the website.